ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Appropriations Hearings Scheduled; Zubro Heads AACI, Nelson Elected ACCC President

February 10, 1978

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

The Lancet Corrects Henschke Letters.

July 18, 2008

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012

Sausville to lead clinical research at Maryland.

December 5, 2003

Preliminary Budget Asks $876 Million for NCI As Carter, Fredrickson Ignore ZBB Justifications

December 16, 1977